Boston Scientific’s CHAMPION-AF trial found the Watchman FLX left atrial appendage closure device to be statistically superior to leading blood thinners in reducing major bleeding, while matching them ...
That number is expected to exceed 8 million – about 3% of the population – by 2030, based on findings from the Heart Failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results